Bank of New York Mellon’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $77.6M | Sell |
146,588
-12,652
| -8% | -$5.84M | 0.01% | 810 |
|
|
2026
Q1 | $76.5M | Sell |
159,240
-237
| -0.1% | -$121K | 0.01% | 764 |
|
|
2025
Q4 | $89.6M | Sell |
159,477
-5,752
| -3% | -$3.27M | 0.02% | 705 |
|
|
2025
Q3 | $85M | Sell |
165,229
-12,601
| -7% | -$5.5M | 0.02% | 724 |
|
|
2025
Q2 | $55.8M | Sell |
177,830
-18,801
| -10% | -$5.64M | 0.01% | 926 |
|
|
2025
Q1 | $59.9M | Sell |
196,631
-3,350
| -2% | -$1.13M | 0.01% | 852 |
|
|
2024
Q4 | $66.4M | Sell |
199,981
-2,308
| -1% | -$783K | 0.01% | 840 |
|
|
2024
Q3 | $67.5M | Sell |
202,289
-23,979
| -11% | -$9.11M | 0.01% | 839 |
|
|
2024
Q2 | $93.2M | Buy |
226,268
+1,128
| +0.5% | +$447K | 0.02% | 680 |
|
|
2024
Q1 | $91M | Sell |
225,140
-20,119
| -8% | -$7.07M | 0.02% | 712 |
|
|
2023
Q4 | $75.2M | Buy |
245,259
+4,779
| +2% | +$1.29M | 0.02% | 809 |
|
|
2023
Q3 | $58.2M | Sell |
240,480
-8,646
| -3% | -$2.21M | 0.01% | 890 |
|
|
2023
Q2 | $59.8M | Sell |
249,126
-33,578
| -12% | -$6.97M | 0.01% | 905 |
|
|
2023
Q1 | $53.2M | Sell |
282,704
-7,453
| -3% | -$1.54M | 0.01% | 976 |
|
|
2022
Q4 | $61.6M | Sell |
290,157
-63,002
| -18% | -$12.6M | 0.01% | 861 |
|
|
2022
Q3 | $55.5M | Buy |
353,159
+50,881
| +17% | +$8.12M | 0.01% | 894 |
|
|
2022
Q2 | $45.2M | Sell |
302,278
-9,640
| -3% | -$1.4M | 0.01% | 1051 |
|
|
2022
Q1 | $51M | Sell |
311,918
-9,601
| -3% | -$1.58M | 0.01% | 1080 |
|
|
2021
Q4 | $70M | Sell |
321,519
-5,664
| -2% | -$1.19M | 0.01% | 919 |
|
|
2021
Q3 | $61.9M | Buy |
327,183
+9,324
| +3% | +$1.7M | 0.01% | 994 |
|
|
2021
Q2 | $56.1M | Buy |
317,859
+320
| +0.1% | +$55.2K | 0.01% | 1063 |
|
|
2021
Q1 | $52.1M | Buy |
317,539
+2,504
| +0.8% | +$383K | 0.01% | 1088 |
|
|
2020
Q4 | $43.9M | Buy |
315,035
+5,955
| +2% | +$751K | 0.01% | 1117 |
|
|
2020
Q3 | $34.5M | Sell |
309,080
-9,720
| -3% | -$1.12M | 0.01% | 1123 |
|
|
2020
Q2 | $29.7M | Sell |
318,800
-3,528
| -1% | -$300K | 0.01% | 1186 |
|
|
2020
Q1 | $23.7M | Buy |
322,328
+3,420
| +1% | +$297K | 0.01% | 1197 |
|
|
2019
Q4 | $26.8M | Sell |
318,908
-13,738
| -4% | -$1.06M | 0.01% | 1397 |
|
|
2019
Q3 | $28M | Buy |
332,646
+13,104
| +4% | +$990K | 0.01% | 1323 |
|
|
2019
Q2 | $20.9M | Sell |
319,542
-102,074
| -24% | -$5.88M | 0.01% | 1550 |
|
|
2019
Q1 | $24.9M | Sell |
421,616
-331,687
| -44% | -$19.8M | 0.01% | 1422 |
|
|
2018
Q4 | $39.9M | Buy |
753,303
+427,062
| +131% | +$23.4M | 0.01% | 1038 |
|
|
2018
Q3 | $19.5M | Buy |
326,241
+240,900
| +282% | +$13.2M | 0.01% | 1637 |
|
|
2018
Q2 | $3.67M | Buy |
85,341
+3,486
| +4% | +$141K | ﹤0.01% | 2541 |
|
|
2018
Q1 | $2.86M | Buy |
81,855
+9,845
| +14% | +$360K | ﹤0.01% | 2629 |
|
|
2017
Q4 | $2.61M | Buy |
72,010
+10,010
| +16% | +$351K | ﹤0.01% | 2694 |
|
|
2017
Q3 | $1.98M | Sell |
62,000
-968
| -2% | -$29.6K | ﹤0.01% | 2849 |
|
|
2017
Q2 | $1.83M | Buy |
62,968
+27,906
| +80% | +$783K | ﹤0.01% | 2906 |
|
|
2017
Q1 | $1.05M | Buy |
35,062
+4,609
| +15% | +$149K | ﹤0.01% | 3212 |
|
|
2016
Q4 | $1.1M | Buy |
30,453
+16,961
| +126% | +$565K | ﹤0.01% | 3210 |
|
|
2016
Q3 | $403K | Buy |
+13,492
| New | +$394K | ﹤0.01% | 3634 |
|
Other funds holding MEDP
WA
Bank of New York Mellon's MEDP Position: Q2 2026 in Review
Bank of New York Mellon reduced its Medpace (MEDP) stake by 7.9% in Q2 2026, selling an estimated $5.84M and leaving 146,588 shares worth $77.6M. The position accounts for 0.01% of the portfolio, ranked #810.
Bank of New York Mellon first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $93.2M in Q2 2024. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Bank of New York Mellon held 146,588 shares of Medpace worth $77.6M as of Q2 2026.
- Bank of New York Mellon sold 12,652 Medpace shares in Q2 2026, an estimated $5.84M.
- Medpace made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #810 holding.
- Bank of New York Mellon first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
- Bank of New York Mellon's Medpace position peaked at $93.2M in Q2 2024.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.